Back to Journals » ImmunoTargets and Therapy » Volume 6

FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights

Total article views   HTML views PDF downloads Totals
11,348 Dovepress* 10,206+ 1,571 11,777
PubMed Central* 1,142 247 1,389
Totals 11,348 1,818 13,166
*Since 2 May 2017

View citations on PubMed Central and Google Scholar